The Role of F-18 PDG PET/CT in I-131 WBS-Negative, Thyroglobulin-Positive Patients with Differentiated Thyroid Cancer
PDF
Cite
Share
Request
Original Article
P: 153-160
December 2011

The Role of F-18 PDG PET/CT in I-131 WBS-Negative, Thyroglobulin-Positive Patients with Differentiated Thyroid Cancer

Eur Arc Med Res 2011;27(3):153-160
1. S.B. Malatya Devlet Hastanesi, Nükleer Tıp Kliniği
2. S.B Trabzon Numune Hastanesi Nükleer Tıp Kliniği
3. S.B. Okmeydanı Eğitim ve Araştırma Hastanesi Nükleer Tıp Kliniği
No information available.
No information available
Received Date: 09.02.2011
Accepted Date: 04.05.2011
PDF
Cite
Share
Request

ABSTRACT

The aim of this study was to evaluate the role of F-18 FDG PET/CT (18f flourodeoxyglucose-pozitron emission tomography / computer tomography) in I-131 WBS-negative, thyroglobulin-positive patients with suspected differentiated thyroid cancer recurrences and metastasis. 30 patients were selected using these criteria. There were 11 males and 19 females. The pathological types of the cancer were as follows: papillary (26) and follicular (4). TSH (thyroid-stimulating hormon) level at the time of FDG PET/BT was suppressed (<2 μIU/ml) in all patients.

FDG PET/CT demonstrated a patient-based sensitivity % 91.3, specificity, % 71.4 positive predictive value of % 91.3 and negative predictive value of % 71.4. Sensitivity and specificity of FDG PET/BT in papillary carsinom classic type were % 88.8, % 33.3, respectively. However sensitivity and specificity of FDG PET/BT in papillary carcinom tall cell variant were % 85.7, % 100, respectively.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House